Special Considerations in Pediatric Lung Transplantation

ABSTRACT

More than 1300 lung or heart-lung transplants have been performed in children to date, resulting in many years of improved quality of life. Increasing experience has demonstrated that this therapy is unique and differs from adult lung transplantation in terms of indications, complications, pharmacokinetics, and monitoring. Unlike adult lung transplant recipients, cystic fibrosis and pulmonary vascular disease are very common indications. Complications such as graft dysfunction and bronchiolitis obliterans occur similarly in children as in adults, but others such as posttransplant lymphoproliferative disorders, growth retardation, respiratory tract infections, and medical nonadherence appear to be more common in pediatric lung transplant recipients. In addition, infants and adolescents are two very distinct populations that require special attention.

Although the new lung allocation system grants some preference to children, donor shortage remains a limiting factor. Living donor lobar transplantation is an alternative for select candidates. Survival rates are similar between adult and pediatric transplant recipients. Support for collaborative studies is critical if we are to improve long-term outcomes for our young patients.

KEYWORDS

Pediatric lung transplantation - infant transplantation - adolescent transplantation - cystic fibrosis - living donor transplantation

REFERENCES

• 1 Huddleston C B, Bloch J B, Sweet S C, de la Morena M, Patterson G A, Mendeloff E N. Lung transplantation in children.  Ann Surg. 2002;  236 270-276
• 2 Waltz D A, Boucek M M, Edwards L B et al.. Registry for the International Society for Heart and Lung Transplantation: Ninth Official Pediatric Report-2006-Lung and Heart-Lung Transplantation.  J Heart Lung Transplant. 2006;  25 904-911
• 3 Trulock E P, Edwards L B, Taylor D O, Boucek M M, Keck B M, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: twenty-second official adult lung and heart-lung transplant report-2005.  J Heart Lung Transplant. 2005;  24 956-967
• 4 Boucek M M, Edwards L B, Keck B M, Trulock E P, Taylor D O, Hertz M I. Registry of the International Society for Heart and Lung Transplantation: eighth official pediatric report-2005.  J Heart Lung Transplant. 2005;  24 968-982
• 5 Egan T M, Murray S, Bustami R T et al.. Development of the new lung allocation system in the United States.  Am J Transplant. 2006;  6 1212-1227
• 6 Alvarez A, Algar F J, Santos F et al.. Pediatric lung transplantation.  Transplant Proc. 2005;  37 1519-1522
• 7 Sundberg A K, Smith L D, Somerville K T, Cox R, Sherbotie J R. Conversion from cyclosporine to tacrolimus is preferred by pediatric renal transplant recipients: a focus on opinions and outcomes.  Transplant Proc. 2002;  34 1951-1952
• 8 Gerson A C, Furth S L, Neu A M, Fivush B A. Assessing associations between medication adherence and potentially modifiable psychosocial variables in pediatric kidney transplant recipients and their families.  Pediatr Transplant. 2004;  8 543-550
• 9 Vidhun J R, Sarwal M M. Corticosteroid avoidance in pediatric renal transplantation.  Pediatr Nephrol. 2005;  20 418-426
• 10 Andrade C F, Martins L K, Tonietto T A et al.. Partial liquid ventilation with perfluorodecalin following unilateral canine lung allotransplantation in non-heart-beating donors.  J Heart Lung Transplant. 2004;  23 242-251
• 11 Visner G A, Faro A, Zander D S. Role of transbronchial biopsies in pediatric lung diseases.  Chest. 2004;  126 273-280
• 12 Klug B, Bisgaard H. Measurement of lung function in awake 2-4-year-old asthmatic children during methacholine challenge and acute asthma: a comparison of the impulse oscillation technique, the interrupter technique, and transcutaneous measurement of oxygen versus whole-body plethysmography.  Pediatr Pulmonol. 1996;  21 290-300
• 13 Nielsen K G, Bisgaard H. Discriminative capacity of bronchodilator response measured with three different lung function techniques in asthmatic and healthy children aged 2 to 5 years.  Am J Respir Crit Care Med. 2001;  164 554-559
• 14 Choong C K, Sweet S C, Zoole J B et al.. Bronchial airway anastomotic complications after pediatric lung transplantation: incidence, cause, management, and outcome.  J Thorac Cardiovasc Surg. 2006;  131 198-203
• 15 Vinograd I, Keidar S, Weinberg M, Silbiger A. Treatment of airway obstruction by metallic stents in infants and children.  J Thorac Cardiovasc Surg. 2005;  130 146-150
• 16 Khalifah A P, Hachem R R, Chakinala M M et al.. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death.  Am J Respir Crit Care Med. 2004;  170 181-187
• 17 Danziger-Isakov L A, Faro A, Sweet S et al.. Variability in standard care for cytomegalovirus prevention and detection in pediatric lung transplantation: survey of eight pediatric lung transplant programs.  Pediatr Transplant. 2003;  7 469-473
• 18 Danziger-Isakov L A, DelaMorena M, Hayashi R J et al.. Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients.  Transplantation. 2003;  75 1538-1543
• 19 Cantu III E, Appel III J Z, Hartwig M G et al.. J. Maxwell Chamberlain Memorial Paper. Early fundoplication prevents chronic allograft dysfunction in patients with gastroesophageal reflux disease.  Ann Thorac Surg. 2004;  78 1142-1151 discussion 1142-1151
• 20 Benden C, Aurora P, Curry J, Whitmore P, Priestley L, Elliott M J. High prevalence of gastroesophageal reflux in children after lung transplantation.  Pediatr Pulmonol. 2005;  40 68-71
• 21 Boyle G J, Michaels M G, Webber S A et al.. Posttransplantation lymphoproliferative disorders in pediatric thoracic organ recipients.  J Pediatr. 1997;  131 309-313
• 22 Sweet S C, de la Morena M, Schuler P, Gandhi S K, Huddleston C B. Lung transplantation in infants and toddlers: comparison of risk factors and outcomes to older children [abstract].  Pediatr Transplant. 2005;  9(Suppl 6) 89
• 23 Sweet S C, Spray T L, Huddleston C B et al.. Pediatric lung transplantation at St. Louis Children's Hospital, 1990-1995.  Am J Respir Crit Care Med. 1997;  155 1027-1035
• 24 Maxwell H, Haffner D, Rees L. Catch-up growth occurs after renal transplantation in children of pubertal age.  J Pediatr. 1998;  133 435-440
• 25 Rodeck B, Kardorff R, Melter M, Ehrich J H. Improvement of growth after growth hormone treatment in children who undergo liver transplantation.  J Pediatr Gastroenterol Nutr. 2000;  31 286-290
• 26 Sweet S C, de la Morena M, Schuler P, Huddleston C B, Mendeloff E. Association of growth hormone therapy with the development of bronchiolitis obliterans syndrome in pediatric lung transplant recipients [abstract].  J Heart Lung Transplant. 2004;  23 S127
• 27 Cohen A H, Mallory Jr G B, Ross K et al.. Growth of lungs after transplantation in infants and in children younger than 3 years of age.  Am J Respir Crit Care Med. 1999;  159 1747-1751
• 28 Ro P S, Bush D M, Kramer S S, Mahboubi S, Spray T L, Bridges N D. Airway growth after pediatric lung transplantation.  J Heart Lung Transplant. 2001;  20 619-624
• 29 Baum M, Freier M C, Chinnock R E. Neurodevelopmental outcome of solid organ transplantation in children.  Pediatr Clin North Am. 2003;  50 1493-1503
• 30 Ringewald J M, Gidding S S, Crawford S E, Backer C L, Mavroudis C, Pahl E. Nonadherence is associated with late rejection in pediatric heart transplant recipients.  J Pediatr. 2001;  139 75-78
• 31 Gaston R S, Hudson S L, Ward M, Jones P, Macon R. Late renal allograft loss: noncompliance masquerading as chronic rejection.  Transplant Proc. 1999;  31 21S-23S
• 32 Liou T G, Adler F R, Huang D. Use of lung transplantation survival models to refine patient selection in cystic fibrosis.  Am J Respir Crit Care Med. 2005;  171 1053-1059
• 33 Sweet S C, Faro A. Not so fast-don't deprive children with cystic fibrosis of the option for lung transplantation.  Am J Respir Crit Care Med. 2006;  173 246-247 , author reply 247-248
• 34 Reiss J G, Gibson R W, Walker L R. Health care transition: youth, family, and provider perspectives.  Pediatrics. 2005;  115 112-120
• 35 Stabile L, Rosser L, Porterfield K M et al.. Transfer versus transition: success in pediatric transplantation brings the welcome challenge of transition.  Prog Transplant. 2005;  15 363-370
• 36 Starnes V A, Barr M L, Cohen R G. Lobar transplantation: indications, technique, and outcome.  J Thorac Cardiovasc Surg. 1994;  108 403-410 , discussion 410-411
• 37 Woo M S, MacLaughlin E F, Horn M V et al.. Living donor lobar lung transplantation: the pediatric experience.  Pediatr Transplant. 1998;  2 185-190
• 38 Woo M S, MacLaughlin E F, Horn M V, Szmuszkovicz J R, Barr M L, Starnes V A. Bronchiolitis obliterans is not the primary cause of death in pediatric living donor lobar lung transplant recipients.  J Heart Lung Transplant. 2001;  20 491-496
• 39 Bowdish M E, Barr M L, Schenkel F A et al.. A decade of living lobar lung transplantation: perioperative complications after 253 donor lobectomies.  Am J Transplant. 2004;  4 1283-1288